Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1.
about
Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit kneesFuture of adenoviruses in the gene therapy of arthritisReduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacityAge-related changes in the response of human articular cartilage to IL-1alpha and transforming growth factor-beta (TGF-beta): chondrocytes exhibit a diminished sensitivity to TGF-beta.Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transferOrthopedic gene therapy in 2008.Gene therapy: design and prospects for craniofacial regeneration.Anticytokine therapy for osteoarthritis.Harnessing biomechanics to develop cartilage regeneration strategies.Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production.Clinical potential and challenges of using genetically modified cells for articular cartilage repair.Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repairMyrtol ameliorates cartilage lesions in an osteoarthritis rat modelGene-based approaches for the repair of articular cartilage.Osteoarthritis gene therapy.Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid.TGF-beta signaling in chondrocytes.Genetic engineering of juvenile human chondrocytes improves scaffold-free mosaic neocartilage graftsGene delivery strategies for cartilage tissue engineeringGene therapy for articular cartilage repair.Persisting high levels of synovial fluid markers after cartilage repair: a pilot studyConcepts in gene therapy for cartilage repair.Berberine ameliorates cartilage degeneration in interleukin-1β-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signallingGrowth factor transgenes interactively regulate articular chondrocytes.Use of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches.Gene Therapy for Cartilage Repair.Incorporation of exudates of human platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilage.Stem cells and gene therapy for cartilage repair.Benefits of recombinant adeno-associated virus (rAAV)-mediated insulinlike growth factor I (IGF-I) overexpression for the long-term reconstruction of human osteoarthritic cartilage by modulation of the IGF-I axis.Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor.IGFBP-5 Metabolism Is Disrupted in the Rat Medial Meniscal Tear Model of Osteoarthritis.Effect of transfection strategy on growth factor overexpression by articular chondrocytes.Regulation of articular chondrocyte aggrecan and collagen gene expression by multiple growth factor gene transfer.IGF-1 does not moderate the time-dependent transcriptional patterns of key homeostatic genes induced by sustained compression of bovine cartilagerAAV-mediated overexpression of TGF-β stably restructures human osteoarthritic articular cartilage in situ.Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model.Platelet-rich plasma increases transforming growth factor-beta1 expression at graft-host interface following autologous osteochondral transplantation in a rabbit model.Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures.Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7.Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
P2860
Q24804324-FA9CCDCF-6C77-4E6F-99BC-357075EC81BBQ24805400-133597EA-31DD-41F4-83AB-6CF3B2D31CE7Q24812968-5427E128-40BB-46C3-8E96-2146ADC656F3Q30988218-779ADB6C-14A4-4F27-9F5B-C25E24264758Q33606440-4C8615E7-285B-4F44-8DC0-3FF4540D4D7DQ33713231-A7F7BCCC-13E6-40F0-A314-BB28A3662E76Q34007347-B6495150-DF04-47C4-928E-EF26A2605DC0Q34452635-AF8C4B8C-86EB-4D33-BD8F-999F616EA4C6Q35062155-A0309686-CAF3-4F6E-B464-74FCA8467D3AQ35070721-0A85D703-410F-440F-8D95-599F19FBA510Q35090336-D1D6D40D-EE6E-445E-9AE8-F321E6C28CF6Q35130994-4013718D-C9CD-47C4-8337-ACF8E76ACA38Q35405312-E0B21FE1-86D8-4647-9119-50ECDABA3D92Q35629558-29A45ECB-BF9B-4642-9988-713949FE7BC8Q35629588-205279DE-F893-44A2-AB09-647757E833A2Q35731942-7498EA38-875D-491A-8147-C152E44AD10AQ35966339-A0AEA82A-90E3-4276-A6B6-70F144F01FA4Q36484742-C5681E33-C41F-4BC1-9DB0-D163E2ADA712Q36502713-378D56A7-30CB-45E7-B631-5EB18C86FFF8Q36932626-736EE54F-A956-47E5-AC07-7C77FA5112B7Q37011640-CD5908E6-4441-4D34-AC4B-E0F529523086Q37099568-285F09EE-559F-4140-966E-400F291AF518Q37595305-FA072828-A613-4D0F-9E3A-4948DBE95D20Q37715441-0B46B337-0974-4C3C-AC68-410E81C30461Q38245620-CE2BD061-6CE2-46F1-8A8C-E25079FFB121Q38526206-FFB1AB84-6EF4-4DBA-A478-AD33AC8E8147Q39406005-2F0803DE-A8BA-4BCD-9EC0-C28808E210E7Q39632126-2062C1DC-35FA-414C-9227-1674B2B78B4EQ39676689-C7CED37D-4BAB-42B6-A875-4F12A1AA762FQ40774788-2A0F0D6D-F1F7-40E9-BEF1-665E686CF18CQ40841021-3C7D23FF-71C8-46BA-99B7-5C44AEFC9F54Q41846147-2EA093DD-E887-45C6-A986-296AC30E2ECBQ41915703-E1EBE74C-1B90-4160-BAA3-4061155AF35AQ41966367-21D4B976-D51C-4F4E-B2C2-57616B0DFC7AQ42269793-9A9DF23B-5D45-4BC2-BFA2-CD832E371603Q42413507-8436B243-8FF9-4060-A8DD-A3E896481681Q43121251-6E6A5024-FB40-447F-8124-C83849022DA5Q43196877-251695CC-6D1F-43E1-A129-530064B9A864Q43741090-5F08ABAB-F8B8-4C15-9A2B-71D8B29EC52FQ44213356-5432C110-FB72-4D3A-B55F-A57692934C21
P2860
Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Genetic enhancement of matrix ...... and absence of interleukin-1.
@en
Genetic enhancement of matrix ...... and absence of interleukin-1.
@nl
type
label
Genetic enhancement of matrix ...... and absence of interleukin-1.
@en
Genetic enhancement of matrix ...... and absence of interleukin-1.
@nl
prefLabel
Genetic enhancement of matrix ...... and absence of interleukin-1.
@en
Genetic enhancement of matrix ...... and absence of interleukin-1.
@nl
P2093
P1476
Genetic enhancement of matrix ...... and absence of interleukin-1.
@en
P2093
Georgescu HI
Ghivizzani SC
Johnstone B
Niyibizi C
Robbins PD
P304
P356
10.1002/1529-0131(200005)43:5<1156::AID-ANR26>3.0.CO;2-M
P577
2000-05-01T00:00:00Z